Cargando…

The Real DAPSI: A Real-World Retrospective Study on Assessing the Efficacy and Safety of a Fixed-Dose Combination of Dapagliflozin and Sitagliptin in the Indian Population

Introduction Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder affecting millions of individuals worldwide. Effective management of T2DM is crucial to prevent complications. Dapagliflozin and sitagliptin are oral anti-diabetic agents that have been shown to provide synergistic effects...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhattacharjee, Rana, Rai, Madhukar, Joshi, Priyanka, Prasad, Ashish, Birla, Ashish
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Other
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632527/ https://www.ncbi.nlm.nih.gov/pubmed/37954782 http://dx.doi.org/10.7759/cureus.46767

Ejemplares similares

PyDapsys: an open-source library for accessing electrophysiology data recorded with DAPSYS
por: Konradi, Peter, et al.
Publicado: (2023)

FRI649 ADMIRE: Assessing Dapagliflozin And Metformin As An Initial Regimen In Diabetes Mellitus For Enhanced Glucose Control
por: Phadke, Dr Uday, et al.
Publicado: (2023)

Automated Resonance Assignment of Proteins: 6 DAPSY-NMR
por: Fiorito, Francesco, et al.
Publicado: (2006)

Eligibility of Dapagliflozin and Empagliflozin in a Real-World Heart Failure Population
por: Håkansson, Erik, et al.
Publicado: (2021)

Fixed drug eruption to sitagliptin
por: Gupta, Mrinal, et al.
Publicado: (2015)

Real world digital photography
por: Eismann, Katrin, et al.
Publicado: (2011)

Real world digital photograph
por: Eismann, Katrin, et al.
Publicado: (2004)

Real world digital video
por: Shaner, Pete, et al.
Publicado: (2004)

SGML in the real world
por: Van Herwijnen, Eric
Publicado: (1993)

Real world evidence: An Indian perspective
por: Dang, Amit, et al.
Publicado: (2016)

"Quantum Diaries" Chronicles World Year of Physics in Real Time, Real Lives
Publicado: (2005)

Interfacing microcomputers to the real world
por: Sargent, Murray, et al.
Publicado: (1981)

Effectiveness of dapagliflozin versus comparators on renal endpoints in the real world: A multicentre retrospective study
por: Fadini, Gian Paolo, et al.
Publicado: (2018)

A Retrospective Analysis of the Treatment Approach to Immune Thrombocytopenia in the Real World
por: Cuervo, Diana M, et al.
Publicado: (2019)

Management of Dermatophytosis: Real-World Indian Perspective
por: Shenoy, Manjunath, et al.
Publicado: (2023)

Sitagliptin, sitagliptin and metformin, or sitagliptin and amitriptyline attenuate streptozotocin-nicotinamide induced diabetic neuropathy in rats
por: Sharma, Ashish Kumar, et al.
Publicado: (2012)

Fixed-dose combination of sitagliptin and metformin for the treatment of type 2 diabetes
por: Reynolds, Jonathan K
Publicado: (2009)

Management of dyslipidemia and hyperglycemia with a fixed-dose combination of sitagliptin and simvastatin
por: Steinberg, Helmut, et al.
Publicado: (2013)

Real world compositing with Adobe Photoshop CS4
por: Moughamian, Dan, et al.
Publicado: (2009)

Real world QuarkXPress 5: for Macintosh and Windows
por: Blatner, David
Publicado: (2002)

Expert Opinion About the Pharmacoeconomic Edge of Low-Cost Dapagliflozin in Type 2 Diabetes Mellitus in Indian Clinical Settings
por: Sharma, Kamal, et al.
Publicado: (2021)

Bioequivalence Evaluation in Healthy Volunteers: New Generic Formulations of Sitagliptin and Sitagliptin–Metformin Fixed-Dose Combination Compared with the Originator Products
por: Schnaars, Yvonne, et al.
Publicado: (2022)

Real-World Observational Study of Glimepiride and Metformin Fixed-Dose Combination Along With Insulin in the Management of Type 2 Diabetes Mellitus: Indian Experience
por: Prasanna Kumar, KM, et al.
Publicado: (2021)

Real-world media ethics: inside the broadcast and entertainment industries
por: Perebinossoff, Philippe
Publicado: (2017)

Effect of Dapagliflozin in Combination with Lobeglitazone and Metformin in Korean Patients with Type 2 Diabetes in Real-World Clinical Practice
por: Seo, Da Hea, et al.
Publicado: (2022)

Efficacy of Dapagliflozin in Southern Europe Across the Spectrum of Characteristics of Type 2 Diabetes: An International Real-World Analysis
por: Fadini, Gian Paolo, et al.
Publicado: (2022)

Cardio–renal–metabolic syndrome: clinical features and dapagliflozin eligibility in a real‐world heart failure cohort
por: Beles, Monika, et al.
Publicado: (2023)

Efficacy and Safety of a Fixed-Dose Combination of Vildagliptin and Pioglitazone in Indian Patients With Type 2 Diabetes Mellitus: A Randomized, Open-Label, Comparative, Phase III Study
por: Erande, Suhas, et al.
Publicado: (2023)

Development of Clinically Optimized Sitagliptin and Dapagliflozin Complex Tablets: Pre-Formulation, Formulation, and Human Bioequivalence Studies
por: Kang, So-Jin, et al.
Publicado: (2023)

Bioequivalence of saxagliptin/dapagliflozin fixed‐dose combination tablets compared with coadministration of the individual tablets to healthy subjects
por: Vakkalagadda, Blisse, et al.
Publicado: (2016)

Role of Cresp(®) in the management of chemotherapy-induced anemia in cancer patients: A real-world clinical practice audit
por: Biswas, Ghanshyam, et al.
Publicado: (2020)

Primary mediastinal germ cell tumours: real world experience in the low middle income (LMIC) setting
por: Joel, Anjana, et al.
Publicado: (2021)

Real-World Clinical and Economic Outcomes of Liraglutide Versus Sitagliptin in Patients with Type 2 Diabetes Mellitus in the United States
por: Li, Qian, et al.
Publicado: (2014)

Removing the barriers to efficient manufacturing : real-world applications of lean productivity
por: Ferguson, Daniel L
Publicado: (2013)

Producing for TV and new media: a real-world approach for producers
por: Kellison, Cathrine
Publicado: (2009)

A Multinational Real-World Study on the Clinical Characteristics of Patients with Type 2 Diabetes Initiating Dapagliflozin in Southern Europe
por: Fadini, Gian Paolo, et al.
Publicado: (2019)

Effects of Dapagliflozin and Sitagliptin on Insulin Resistant and Body Fat Distribution in Newly Diagnosed Type 2 Diabetic Patients
por: Sun, Yue, et al.
Publicado: (2020)

Development and optimization of sitagliptin and dapagliflozin loaded oral self-nanoemulsifying formulation against type 2 diabetes mellitus
por: Kazi, Mohsin, et al.
Publicado: (2020)

Real-World Experience in Toxicity with Bevacizumab in Indian Cancer Patients
por: Patil, Pratik P., et al.
Publicado: (2021)

The Use of Apremilast in Psoriasis: An Indian Perspective on Real-World Scenarios
por: Rajagopalan, Murlidhar, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5b1kshpvfbgu9232u3n4lpp7ii